Christine Nase
GlaxoSmithKline (United States) · 1 works · 454 citations · h-index 1
Top works
Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial